TransMedics is reaffirming its full-year guidance for revenue growth between 76% and 84% compared to 2023. According to ...
The stock is now down more than 25% for the year and more than 80% from its all-time high, set earlier this year. With that kind of decline, some investors may wonder if it's a stock with some value ...
TD Cowen analyst Marc Frahm maintained a Buy rating on Shattuck Labs (STTK – Research Report) yesterday. The company’s shares ...
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...
The developer has a lot going for it, but the market has cottoned on and the share price may have reached the end of the road ...
Starbucks stock has rallied hard since Brian Niccol was tapped as the coffee chain's new CEO, but one analyst thinks ...
Montreal’s transit authority (STM) is facing backlash over its decision to close the Cabot Square entrance to the Atwater ...
Research Solutions (NASDAQ:RSSS – Get Free Report) is set to release its earnings data after the market closes on Thursday, November 14th. Parties that wish to listen to the company’s conference call ...